New
Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →
Advertisement
Advertisement
IHEvsETF 2ETF Comparison
Choose a second ETF to run a side-by-side ETF comparison with IHE, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
IHE performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 03/11/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | IHE ETF 2 | -1.82%– | +5.93%– | +4.30%– | +28.47%– | +63.32%– | +61.21%– |
| Flows | IHE ETF 2 | +$9M– | +$154M– | +$129M– | +$248M– | +$359M– | +$393M– |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | IHE ETF 2 | +15.86%– | +20.40%– | +15.94%– | +15.80%– |
| Max drawdown | IHE ETF 2 | -4.49%– | -14.18%– | -16.04%– | -16.12%– |
| Max drawdown duration | IHE ETF 2 | 10d– | 150d– | 210d– | 669d– |
Trading data
IHE | ETF 2 | |
Last sale 3/12/2026 at 1:30 PM | $86.66 | – |
| Previous close 03/11/2026 | $88.40 | – |
| Consolidated volume 03/11/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Replication quality
Data as of February 27, 2026
1-year trailing difference
Create an account to view replication metrics
Join for free
IHE | ETF 2 | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
Advertisement
Main metrics
Last update 3/12/2026 at 1:30 PM
Live
Closed
IHE | ETF 2 | |
|---|---|---|
| Last price | $86.66 | – |
| 1D performance | -1.97% | – |
| AuM | $1.02 B | – |
| E/R | 0.38% | – |
Characteristics
IHE | ETF 2 | |
|---|---|---|
| Management strategy | Passive | – |
| Provider | iShares | – |
| Benchmark | Dow Jones U.S. Select Pharmaceuticals Index | – |
| N° of holdings | 46 | – |
| Asset class | Equities | – |
| Trailing 12m distribution yield | Join | Join |
| Inception date | May 1, 2006 | – |
| ESG | No | – |
Advertisement
Exposure
Countries
IHE
USA
90.92%
Other
9.08%
ETF 2
Sectors
IHE
Health Care
96.19%
Other
3.81%
ETF 2
Advertisement
Diversification
IHE
Total weight of top 15 holdings out of 15
84.8%
ETF 2
–
Top 15 holdings
Data as of January 31, 2026
IHE
JOHNSON&JOHNSON
23.72%
LILLY
22.21%
MERCK & CO INC
4.78%
BRISTOL-MYERS SQUIBB
4.57%
ZOETIS INC
4.44%
PFIZER
4.36%
ROYALTY PHARMA
4.08%
VIATRIS INC
4.00%
ELANCO ANIMAL HEALTH INC
3.20%
JAZZ PHARMACEUTICALS
2.65%
AXSOME THERA CMN STK
2.09%
CRINETICS PHARMACEUTICALS
1.41%
US45579U1097
1.15%
CORCEPT THERAPEUTICS
1.11%
LIGAND PHARMACEUTICALS
1.02%
ETF 2
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
Advertisement
Latest news about IHE
Analyzing the Potential ETF Winners & Losers from The Weight-Loss Drug Craze
November 20, 2023
IHE
Healthcare Stocks Rebound
August 14, 2023
IHE
Health is Wealth: A look at the Healthcare Sector
January 24, 2023
IHE
Advertisement
Advertisement
Advertisement
The Active Trader Report
Active Trader Report: Use of Leveraged & Inverse ETFs Way Up
Direxion partnered with Compound Insights and Vanda to explore what’s driving the evolution of active trading — and how active traders are using leveraged and inverse funds across equities, single stocks, commodities, and volatility.
